Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

Status:
Completed

Trial end date:
2004-03-01

Target enrollment:

Participant gender:

This purpose of this study is to assess the safety of ramelteon, once daily (QD), in subjects with chronic obstructive pulmonary disease.

Phase 2

Takeda